Showing results (71-80 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactionsTolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 23, 2021
Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthmaTolly G Epstein, Karen Murphy-Berendts, Gary M Liss, et al.
Virology|November 5, 2023
Selection, activity, and nuclease stabilization of cross-neutralizing DNA aptamers targeting HSV-1 and HSV-2Michael D Schump, David I Bernstein, Fernando J Bravo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2019
AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine AutoinjectorsTolly G Epstein, Gary M Liss, Karen Murphy Berendts, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?Tolly G Epstein, Gary M Liss, Karen Murphy-Berendts, et al.
The Pediatric Infectious Disease Journal|January 25, 2003
Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in childrenDavid I Bernstein, Lihan Yan, John Treanor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 17, 2022
Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World StudyNajeeb Khan, Tolly G Epstein, Ilona DuBuske, et al.
The Journal of Applied Laboratory Medicine|July 20, 2022
Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 EraDavid I Bernstein, Asuncion Mejias, Barbara Rath, et al.
The Journal of Infectious Diseases|October 31, 2002
Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infantsDavid I Bernstein, David A Sack, Keith Reisinger, et al.
The Pediatric Infectious Disease Journal|September 20, 2011
Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative childrenDavid I Bernstein, Elissa Malkin, Nazha Abughali, et al.
Pageof 33